Fixed drug eruption and generalized bullous fixed drug eruption: Insights from an analysis of the FDA Adverse Event Reporting System.

HOME
>
論文・技術情報
>
Fixed drug eruption and generalized bullous fixed drug eruption: Insights from an analysis of the FDA Adverse Event Reporting System.

アブストラクト
ジャーナル名	The journal of allergy and clinical immunology. In practice
Pubmed追加日	2024/10/4
投稿者	Shrestha, P; Stone, C A Jr; Phillips, E J
組織名	Division of Allergy, Pulmonary and Critical Care Medicine, Department of;Medicine, Vanderbilt University Medical Center, Nashville, Tenn.;Medicine, Vanderbilt University Medical Center, Nashville, Tenn; Department of;Medicine, Center for Drug Safety and Immunology, Vanderbilt University Medical;Center, Nashville, Tenn.;Center, Nashville, Tenn; Institute for Immunology and Infectious Diseases,;Murdoch University, Murdoch, Western Australia. Electronic address:;elizabeth.j.phillips@vanderbilt.edu.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/39362487/